Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Parkinson's disease according to a recognised set of medical guidelines called the MDS Criteria
- People whose Parkinson's disease is at a mild to moderate stage (rated as Stage I, II, or III on a scale called Hoehn and Yahr)
- People who have at least some difficulty with walking, as measured by a standard Parkinson's disease assessment tool called the MDS-UPDRS
- People who have read the study information and signed a consent form agreeing to take part
Who may not be able to join:
- People who have a known health condition that could make unsupervised physical exercise unsafe or unsuitable for them
- People experiencing moderate or severe depression, as measured by a standard questionnaire (a score of 18 or higher on the BDI-II scale)
- People whose thinking or memory difficulties may prevent them from fully understanding and consenting to the study
- People who have difficulty understanding everyday conversation (understanding less than 75% of ordinary conversation)
- People with a serious psychiatric condition that may make it difficult to follow the study plan
- People who currently have, or have a history of, dependency on alcohol or other substances
- People who are unable to walk at least one flight of stairs (confirm with trial site)
- People who have experienced chest or upper back pain in the past four weeks
- People who are currently taking part in another clinical study involving a treatment or intervention
- People who have a deep brain stimulation device already implanted
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matthew Brodie, PhD, University of New South Wales
Phone: +614 4988 6272
Australian sites
+61 449 886 272
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Gait speed
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.